Download presentation
Presentation is loading. Please wait.
1
Alterations of Lipid Metabolism in Diabetes Mellitus
2
Lecture Outline Type 1 diabetes Type 2 diabetes
Changes in lipid metabolism are a CONSEQUENCE of diabetes Type 2 diabetes Changes in lipid metabolism may be a CAUSE of diabetes AND
3
Normal Pancreatic Function
Exocrine pancreas aids digestion Bicarbonate Lipase Amylase Proteases Endocrine pancreas (islets of Langerhans) Beta cells secrete insulin Alpha cells secrete glucagon Other hormones
4
Type 1 Diabetes Mellitus: Background
Affects ~1 million people Juvenile onset Genetic component Autoimmune/environmental etiology
5
Type 1 Diabetes: Hallmarks
Progressive destruction of beta cells Decreased or no endogenous insulin secretion Dependence on exogenous insulin for life
6
Diabetes: General Information
Juvenile Diabetes Research Foundation American Diabetes Association
7
Type 1 Diabetes: Presenting Symptoms
Polyuria Polydipsia Hyperphagia Growth retardation Wasting
8
Insulin Stimulates Cellular Glucose Uptake
Adipocytes Skeletal Muscle Liver Insulin Intestine & Pancreas
9
Absence of Insulin Glucose cannot be utilized by cells
Glucose concentration in the blood rises Blood glucose concentrations can exceed renal threshold Glucose is excreted in urine
10
Presenting Symptoms of Type 1 Diabetes
Polyuria: Glucose excretion in urine increases urine volume Polydipsia: Excessive urination leads to increased thirst Hyperphagia: “Cellular starvation” increases appetite
11
Growth Retardation Insulin required for normal growth
Necessary for normal amino acid and protein metabolism Stimulates synthesis, inhibits degradation
12
Wasting Calories are inefficiently stored as fat
Adipose stores are depleted
13
Normal Insulin Glycerol Lipolysis Free fatty acids Triglyceride
LPL Triglyceride Lipolysis Glycerol Free fatty acids Free fatty acids Glucose Synthesis Insulin
14
Type 1 Diabetes Mellitus
Triglyceride LPL Glycerol Lipolysis Free fatty acids Synthesis Free fatty acids Glucose
15
Clinical Chemistry Normal Uncontrolled Type 1
Fasting blood glucose < 100 mg/dL Serum free fatty acids ~ 0.30 mM Serum triglyceride ~100 mg/dL Uncontrolled Type 1 Fasting blood glucose up to 500 mg/dL Serum free fatty acids up to 2 mM Serum triglyceride > 1000 mg/dL
16
Adipocyte Fatty Acid Uptake Decreased
Lipoprotein lipase Synthesized by adipocytes Secreted to capillary endothelium Hydrolyzes circulating triglyceride Fatty acid transporter CD36, FABPpm Facilitates movement of free fatty acids from extracellular to intracellular space
17
Adipocyte Triglyceride Synthesis Decreased
Glycerol-3-P FACoA Lysophosphatidic acid FACoA Phosphatidic acid Pi Diglyceride FACoA Triglyceride
18
Antilipolysis a b AC ATP cAMP PKA HSL Perilipin PKB AMP PDE PI3K IRS
Gs Gi AC AC PDE ATP cAMP PKA HSL Perilipin PI3K PKB Might have to make this one AMP
19
Enhanced Lipolysis: Consequences in Liver
Liver partitions fatty acids: Triglyceride synthesis (VLDL) Oxidation Ketogenesis
20
Insulin Regulation of Hepatic Fatty Acid Partitioning
FA-CoA TG ATP, CO2 -hydroxybutyrate acetoacetate Mitochondrion
21
In Liver: FFA Entry into Mitochondria is Regulated by Insulin/Glucacon
Malonyl CoA carnitine carnitine FA-CoA CPT-II FA-CoA CPT-I ATP, CO2 HB, AcAc inner outer TG Mitochondrial membranes
22
Malonyl CoA is a Regulatory Molecule
Condensation of CO2 with acetyl CoA forms malonyl CoA First step in fatty acid synthesis Catalyzed by acetyl CoA carboxylase Enzyme activity increased by insulin
23
Ketone Bodies Hydroxybutyrate, acetoacetate Fuel for brain
Excreted in urine At mM reduce pH of blood Can cause coma (diabetic ketoacidosis)
24
Type 1 Diabetes Summary Lack of insulin prevents storage of lipid in adipose tissue Unstored lipid circulates as lipoproteins and free fatty acids Free fatty acids are oxidized by liver to form ketone bodies
25
Type 2 Diabetes Mellitus
16 million estimated affected Genetic component Associated with obesity Previously maturity-onset Progressive
26
How is Glucose Tolerance Measured?
Oral Glucose Tolerance Test (OGTT) Fasting state 75 gm oral glucose load Blood sampled before and at intervals for 2-4 hr. Serum glucose measured clinically Serum insulin measured experimentally
27
Oral Glucose Tolerance Test
Normal Low basal glucose Small, transient rise in glucose Low basal insulin, two-phase, transient increase in insulin
28
Oral Glucose Tolerance Test
Insulin Resistant Tissues unresponsive to insulin Basal hyperinsulinemia First phase insulin release blunted Blood glucose curve looks normal
29
Oral Glucose Tolerance Test
Impaired Glucose Tolerance Deterioration in ability to handle glucose Basal and stimulated hyperinsulinemia Fasting plasma glucose >100, <126 mg/dL 2 hr glucose >140, <200 mg/dL
30
Oral Glucose Tolerance Test
Diabetes Mellitus Hyperinsulinemia can’t compensate for insulin resistance Fasting blood glucose >126 mg/dL 2 hr glucose >200 mg/dL Insulin resistance increases
31
“Lipotoxicity” hypothesis
Ectopic deposition of lipid contributes to the etiology and progression of T2DM. “Lipotoxicity” hypothesis
32
Bad Places for Excess Lipid
Liver Skeletal Muscle Heart Muscle Pancreas
33
Primary Defect in Type 2 Study healthy 1st degree relatives of patients with type 2 Measure ability of body to use glucose Find defects in muscle glucose uptake before any symptoms develop
34
150 mg/dL 3. Adjust glucose infusion rate to maintain euglycemia.
Insulin 1. Infuse insulin to induce hyperinsulinemia 2. Measure blood glucose every 2 min 150 mg/dL
35
Clamp Data The amount of glucose infused is a measure of insulin sensitivity. More glucose = more sensitive Less glucose = less sensitive McGarry 2002, Fig 2B
36
Findings from Clamp Studies
Glucose disposal is decreased 60% in some healthy young people with family history of type 2. Defect is in ability of insulin to stimulate glucose transport into the cell.
37
Why is Glucose Transport Reduced?
Mitochondrial phosphorylation decreased 30% Intramyocellular lipid is increased 80% Ectopic fat may hinder insulin-stimulation of glucose transport.
38
Lipids as Signaling Molecules
Fatty acyl CoA esterified to diglyceride Diglyceride activates protein kinase C theta Protein kinase C theta serine- phosphorylates and inactivates insulin receptor substrate 1
39
What is consequence of muscle insulin resistance?
Pancreas compensates > hyperinsulinemia Hyperinsulinemia exacerbates insulin resistance in adipose tissue.
40
Consequences of Insulin Resistance in Adipose Tissue
Similar to insulin deficiency Reduced TG synthesis Enhanced lipolysis Net increase in FA availability to non-adipose tissues
41
Effect of excess free fatty acids on insulin sensitivity
42
Consequences of Insulin Resistance FFA in Muscle
Increased intramyocellular lipid Hypothetical: inhibition of insulin signaling by diglyceride Reduction in glucose uptake by muscle
43
Consequences of Insulin Resistance FFA in Liver
Increased triglyceride synthesis Increased oxidation Increased gluconeogenesis Hepatic glucose output contributes to hyperglycemia
44
Consequences of Insulin Resistance FFA in Pancreas
Animal models of diabetes Lipid droplets accumulate in beta cells Beta cells undergo apoptosis Reduced beta cell mass Decreased circulating insulin
45
Pancreatic Histology Diabetic Control
46
Timeline: Development of Type 2
Genetic predisposition Environmental insult Insulin resistance Increased lipolysis Ectopic fat deposition Compromised pancreatic function Fasting Hyperglycemia Beta cell failure
47
Diet and Exercise Goal Purpose Reduce caloric intake Increase exercise
Reduce size of adipose stores Improve insulin sensitivity Increase lean body mass
48
Insulin-releasing Drugs
Goal Stimulate pancreas to produce more endogenous insulin Purpose Overcomes insulin resistance Plasma glucose is taken up and oxidized appropriately
49
Hepatic Insulin Sensitizers
Goal Work selectively on the liver Inhibit glycogenolysis and gluconeogenesis Purpose Reduce hepatic glucose output Reduce blood glucose concentration
50
Thiazolidinediones: new class of drugs
Goal Peripheral insulin sensitizers Enhance muscle insulin sensitivity Purpose Reduce blood glucose, insulin
51
Thiazolidinediones: new class of drugs
Unintended consequences Increase lipid storage in adipose tissue Reduce lipid storage in muscle, pancreas Preserve beta cell mass
52
Summary Insulin deficiency perturbs lipid metabolism in type 1 diabetes. Prevention Under investigation Treatment Insulin replacement Management of carbohydrate intake
53
Summary, cont. Dysregulated lipid metabolism may contribute to the development of type 2 diabetes. Prevention Eat less, exercise more really works Treatment Depends on stage of disease
Similar presentations
![Fatty Acid Metabolism. Introduction of Clinical Case n 10 m.o. girl –Overnight fast, morning seizures & coma –[glu] = 20mg/dl –iv glucose, improves rapidly.](/13/4088684/big_thumb.jpg "Fatty Acid Metabolism. Introduction of Clinical Case n 10 m.o. girl –Overnight fast, morning seizures & coma –[glu] = 20mg/dl –iv glucose, improves rapidly.>")
